bortezomib,carfilzomib,dexamethasone,elotuzumab,cc-92480,daratumumab,isatuximab
takeda,bms,janssen,sanofi,amgen
oral abstracts day2 #ims2022 nct03989414: phase 1/2 - a study of mezi (cc-92480) with standard treatments in relapsed &amp; new mm - mm-002 #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community